Dumont FJ et al. |
Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. |
1990 |
J. Immunol. |
pmid:1688572
|
Woo J et al. |
Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal. |
1990 |
Clin. Exp. Immunol. |
pmid:1689226
|
Dumont FJ et al. |
The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. |
1990 |
J. Immunol. |
pmid:1689353
|
Brown Z and Neild GH |
FK-506 and haemolytic uraemic syndrome. |
1990 |
Lancet |
pmid:1689442
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Yamamoto K et al. |
Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. |
1990 |
Immunology |
pmid:1689694
|
Thomson AW |
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689883
|
Li PK et al. |
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. |
1990 |
Adverse Drug React Acute Poisoning Rev |
pmid:1703724
|
Imventarza O et al. |
Renal transplantation in baboons under FK 506. |
1990 |
Transplant. Proc. |
pmid:1689903
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Ericzon BG et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey. |
1990 |
Transplant. Proc. |
pmid:1689905
|
Murase N et al. |
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689906
|
Hoffman AL et al. |
The effect of FK 506 on small intestine allotransplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1689907
|
Lee KK et al. |
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. |
1990 |
Transplant. Proc. |
pmid:1689908
|
Ueda Y et al. |
Induction of graft acceptance after dog kidney or liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689909
|
Ohara K et al. |
Toxicologic evaluation of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689910
|
Nalesnik MA et al. |
The effect of FK 506 and CyA on the Lewis rat renal ischemia model. |
1990 |
Transplant. Proc. |
pmid:1689911
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Mazzaferro V et al. |
Studies of the hepatotrophic qualities of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689913
|
Kay JE et al. |
The mechanism of action of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689914
|
Suzuki N et al. |
Effects of a novel immunosuppressive agent, FK506, on human B cell activation. |
1990 |
Clin. Exp. Immunol. |
pmid:1690097
|
McCauley J et al. |
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. |
1990 |
Lancet |
pmid:1690326
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Maruyama M et al. |
Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. |
1990 |
Transplantation |
pmid:1696410
|
Standaert RF et al. |
Molecular cloning and overexpression of the human FK506-binding protein FKBP. |
1990 |
Nature |
pmid:1696686
|
Tropschug M et al. |
Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding. |
1990 |
Nature |
pmid:1696687
|
Randall T |
New antirejection drugs anticipated. |
1990 |
JAMA |
pmid:1696999
|
Metcalfe S et al. |
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells. |
1990 |
Transplant. Proc. |
pmid:1697107
|
Morris RE et al. |
A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. |
1990 |
Transplant. Proc. |
pmid:1697111
|
Woo J et al. |
Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. |
1990 |
Transplant. Proc. |
pmid:1697112
|
Woo J et al. |
Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis. |
1990 |
Transplant. Proc. |
pmid:1697113
|
Propper DJ et al. |
Low-dose FK 506 inhibits sensitisation after blood transfusions. |
1990 |
Transplant. Proc. |
pmid:1697114
|
Tiebosch A et al. |
Side effects of FK 506 in cynomolgus monkeys: a histopathologic study. |
1990 |
Transplant. Proc. |
pmid:1697115
|
Dammeijer PF et al. |
Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival. |
1990 |
Transplant. Proc. |
pmid:1697116
|
Imai K et al. |
Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1697117
|
Iga C et al. |
Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin. |
1990 |
Transplant. Proc. |
pmid:1697118
|
Deguchi K et al. |
[Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis]. |
1990 |
No To Shinkei |
pmid:1697182
|
Granelli-Piperno A et al. |
The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. |
1990 |
J. Exp. Med. |
pmid:1701825
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Takai K et al. |
Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry. |
1990 |
Clin. Exp. Immunol. |
pmid:1702372
|
Okubo Y et al. |
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. |
1990 |
Clin. Exp. Immunol. |
pmid:1702373
|
Arita C et al. |
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. |
1990 |
Clin. Exp. Immunol. |
pmid:1702374
|
Woo J et al. |
Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. |
1990 |
Clin. Exp. Immunol. |
pmid:1702375
|
Mattila PS et al. |
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. |
1990 |
EMBO J. |
pmid:1702384
|
Kawashima H et al. |
Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. |
1990 |
Invest. Ophthalmol. Vis. Sci. |
pmid:1702408
|
Wilkinson PC and Watson EA |
FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes. |
1990 |
Immunology |
pmid:1702750
|
Metcalfe S and Milner J |
Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation. |
1990 |
Immunol. Lett. |
pmid:1702753
|
Takada K et al. |
Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection. |
1990 |
J. Chromatogr. |
pmid:1703552
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|